You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

clazakizumab

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Kidney Failure, Chronic, End-Stage Renal Disease, Transplant Glomerulopathy Trial in Los Angeles (Clazakizumab)

Active, not recruiting
  • Kidney Failure, Chronic
  • +6 more
  • Clazakizumab
  • Los Angeles, California
    Norko Ammerman
Mar 25, 2022

Antibody-mediated Rejection, Kidney Transplant; Complications, Transplant Glomerulopathy Trial in Los Angeles (Clazakizumab)

Active, not recruiting
  • Antibody-mediated Rejection
  • +5 more
  • Clazakizumab
  • Los Angeles, California
    Norko Ammerman
Mar 25, 2022

COVID-19 Trial in Los Angeles (Clazakizumab)

Completed
Has Results
  • COVID-19
  • Clazakizumab
  • Los Angeles, California
    Cedars-Sinai Medical Center
Nov 30, 2021

Inflammation, Frailty Trial in Pittsburgh (Clazakizumab, Placebo)

Not yet recruiting
  • Inflammation
  • Frailty
  • Clazakizumab
  • Placebo
  • Pittsburgh, Pennsylvania
    University of Pittsburgh, Health Studies Research Center
Feb 3, 2023

COVID-19 Trial in Phoenix, Baltimore, New York (Clazakizumab 25 mg, Clazakizumab 12.5 mg, Placebo)

Recruiting
  • Covid19
  • Clazakizumab
  • Placebo
  • Baltimore, Maryland
    Johns Hopkins Hospital
Jun 10, 2021

COVID-19 Trial in Phoenix, Baltimore, New York (Clazakizumab 25 mg, Clazakizumab 12.5 mg, Placebo)

Completed
  • Covid19
  • Respiratory Failure
  • Clazakizumab
  • Placebo
  • Phoenix, Arizona
    Mayo Clinic in Arizona
Mar 2, 2021

Rheumatoid Arthritis Trial in Worldwide (Clazakizumab, Placebo (Matching with Clazakizumab))

Completed
Has Results
  • Rheumatoid Arthritis
  • Clazakizumab
  • Placebo (Matching with Clazakizumab)
  • Huntsville, Alabama
  • +54 more
Apr 16, 2021